Category Archives: Memos and Alerts

COVID-19 – Ibuprofen & NSAIDs Advice from NICE, MHRA & NHSEI

The Chief Executives of NICE & the MHRA and the National Medical Director for NHS England & NHS Improvement have written to healthcare professionals with the following advice: The [CHM] Expert Working Group on coronavirus (COVID-19) has concluded that there is currently insufficient evidence to establish a link between use of ibuprofen, or other non-steroidal anti-inflammatory drugs (NSAIDs), Continue Reading »

COVID-19 – Professional Resources & Guidance

NHS England COVID-19 Guidance – NHS England COVID-19 Specialty Guides  UK Government COVID-19 resources – NHS COVID-19 resources NICE COVID-19 resources – NHS SPS COVID-19 resources – RDTC HEE e-Learning for Health COVID-19 Courses Medicines for End of Life & Critical Care Alphabetical List – with thanks to SPS Several Professional, Academic & Representative Bodies have compiled collections of COVID-19 guidance Continue Reading »

COVID-19 – Warfarin

The NHS Specialist Pharmacy Service have published a guide to Management of patients taking warfarin during the COVID-19 pandemic. [See also: Guidance for Safe Switching of Warfarin to DOACs] The guide recommends a stepwise approach: For patients with prior DVT or PE with low risk of recurrence, consider stopping warfarin. For other patients, consider switching to a DOAC Continue Reading »

COVID-19 – Anticoagulant Services Clinical Guide

NHSE&I have published a Clinical guide for the management of anticoagulant services during the coronavirus pandemic – as part of the NHSE&I COVID-19 Collection of Specialty Guides  Patients receiving warfarin requiring management in outpatient or community settings – Anticoagulation service provision should consider the following: Is warfarin still required? Can patients on warfarin be switched to an alternative Continue Reading »